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Abstract In several studies peripheral blood T-cells have
been quantiWed, yet few data are available on lymphocyte
subsets in moderate-to-severe psoriasis (in terms of extent
and activity of lesions) versus mild psoriasis. The objective
is to compare lymphocyte subsets in peripheral blood of
patients with moderate-to-severe disease (PASI-score ¸12)
to patients with mild disease (PASI-score <12) and to
healthy subjects. By means of Xow cytometry method, lym-
phocytes in peripheral blood of 27 patients with psoriasis
and 10 healthy controls were characterized. The absolute
number of total lymphocytes was markedly decreased in
patients with moderate-to-severe psoriasis as compared to
patients with mild disease and normal subjects. Cellcounts
of all analysed subsets were found to be increased in more
severe psoriasis, except for CD8+CD45RO+ cells. The
under-representation of CD8+CD45RO+ cells is compati-
ble with the dynamics of acquired immunity, which
requires a time log after the relapse of the lesions to diVer-
entiate from CD45RA+ naive cells.
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Introduction
Psoriasis is a common inXammatory skin disease character-
ized by hyperproliferation of keratinocytes. It is a well
established fact that T-cells play an important role in the
pathogenesis of psoriasis [6, 9]. Indeed, treatments such as
anti-CD4 [5, 15, 19], anti-CD11 [5, 13] and anti-CD25
[13], targeting at speciWc T-cells, have shown to be eVec-
tive in psoriasis. Several T-cell subsets seem to play a pri-
mary role. Major classes are CD4+, CD8+, CD45RO+ and
CD45RA+ T-cells. Recently, NK-T cells have been sug-
gested to play an additional role in the regulation of immu-
nity, through the release of cytokines [3, 14, 16]. NK-T
cells are cells bearing both T cell receptors as well as natu-
ral killer-cell speciWc receptors such as CD161. It has been
shown that circulating NK-T cells are signiWcantly reduced
in some autoimmune diseases [8, 17].
The large body of research on the role of T-cells in pso-
riasis has been focused on lesional T-cells. This has
resulted in the hypothesis that there is a Wnal common path-
way responsible for the development of chronic plaque pso-
riasis, which may involve speciWc antigen recognition by
T-cells that results in stimulation of keratinocyte proliferation.
In psoriasis, CD4+ cells seem to be important mainly in the
early phase of plaque development. These cells are found
predominantly in the upper dermis, whereas CD8+ cells
have proven to be relevant during chronic phases and are
found predominantly in the epidermis [21], although others
have found a more early involvement of CD8+ T-cells in
the development of psoriatic plaques [22]. A large number
of activated T-cells have been shown in clinically involved
skin of psoriatic patients, but also uninvolved skin contains
a signiWcant number of T-cells. In healthy skin, however,
T-cells can hardly be found. It has been suggested that cir-
culating T-cells are activated and subsequently recruited
from the circulation during the development of psoriatic
plaques [2, 10].
Several studies have investigated peripheral blood
T-cells of psoriatic patients [1–3, 7, 10, 12, 14, 20, 21].
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patients is comparable or slightly increased as compared to
that found in normal subjects. No relevant diVerences have
been shown with respect to total T-cell counts and T-cell
subsets including CD4+, CD8+, CD45RO+ and CD45RA+
cell counts. Only few studies comprise a comparison
between mild and more severe forms of psoriasis, using
clinical severity indicators such as the Psoriasis Area and
Severity Index (PASI-score) [4, 18].
The present study compares speciWc circulating lympho-
cyte subsets in patients with mild psoriasis, patients with
moderate-to-severe psoriasis and normal subjects.
Materials and methods
Patients and controls
Fifteen patients with moderate-to-severe psoriasis vulgaris
(12 male and three female aged 19–66, mean age
46.2 years) and 12 patients with mild psoriasis (seven male
and Wve female, aged 34–72, mean age 52.8 years) from
our outpatient department participated in this study. Mean
PASI-scores in both groups were 20.97 § 2.55
(mean § SEM) and 6.11 § 1.27, respectively. Patients
were classiWed into one of both groups based on their
PASI-score. We considered all patients with a PASI-score
<12 as having a “mild”, and all patients with a PASI >12 as
having a “moderate-to-severe” psoriasis [4, 18].
Patients were free of any systemic therapy for at least
4 weeks and did not use any topical therapy in the last
2 weeks. Peripheral blood was obtained from all subjects
with their written informed consent.
Control samples were collected from 10 healthy volun-
teers without any history or signs of skin disease (four male
and six female aged 24–49, mean age 33.8 years).
Preparation of PBMC’s
For each patient, the exact amount of blood withdrawn was
determined by measuring the height of the column of blood
in the tube, which was subsequently converted to the corre-
sponding volume in microliter.
PBMC’s were isolated from heparinized blood by den-
sity centrifugation on polyester gel (Becton Dickinson Vac-
utainer™ CPT™, Franklin Lakes NJ, USA). After Wltering
through a 70 m cellstrainer, cells were washed twice.
For Xow cytometry, single-cell suspensions (concentra-
tion 5 £ 105 cells ml¡1) were stained in 1% fetal calf serum
in phosphate-buVered saline (PBS) at concentrations rec-
ommended by the manufacturer. Additionally, 450 l pro-
pidium iodide (PI) in PBS was added to each sample in
order to exclude non-viable cells from analysis.
The following monoclonal antibodies were used: Xuo-
rescein isothiocyanate (FITC)-conjugated anti-CD4, FITC-
conjugated anti-CD8, phycoerythrin (PE)-conjugated anti-
CD4, PE-conjugated anti-CD8, PE-conjugated anti-CD94
and PE-conjugated anti-CD161 (all from Immunotech,
Marseille, France), as well as FITC-conjugated anti-
CD45RA (Becton Dickinson, San Jose, CA, USA) and
FITC-conjugated anti-CD45RO (DAKO, Glostrup, Dan-
mark).
Flowcytometric analysis
Cells were analyzed with an EPICS Elite Xow cytometer
(Coulter, Luton, UK), using the forward scatter as a dis-
criminator. Lymphocytes were identiWed by gating on
CD45 and side and forward scatter properties. All samples
were processed within 18 h of phlebotomy.
The following (combinations of) PE and FITC-conju-
gated reagents were used to determine the expression of
each antigen or antigen combination on lymphocytes
derived from peripheral blood: CD4+ (marker for T-helper
cells), CD8+ (marker for cytotoxic T cells), CD45RA+
(marker for naïve T-cells), CD45RO+ (marker for memory
T-cells), CD94+ (marker for NK-cells, T cells), CD161+
(marker for NK-cells, T-cells with memory phenotype),
CD4+ CD45RA+, CD4+ CD45RO+, CD8+ CD45RA+,
CD8+ CD45RO+, CD8+ CD94+ and CD8+CD161+.
Determination of absolute numbers of lymphocytes
Enumeration of positive cells was performed by adding
Flow Count Beads (Beckman Coulter, Fullerton, CA, USA)
to the cell suspension of PBMCs. An automatic stop after a
deWned amount of beads was programmed on the Xow
cytometer. Absolute counts of lymphocyte subsets per blood
sample were calculated by determining the ratio of the beads
to the cell population and then multiplying this ratio by the
number of beads in the tube. By dividing this count by the
amount of microliters in the tube, a relative absolute lym-
phocyte count in cells l¡1 blood withdrawn was obtained.
Analysis was performed with Verity software.
Ratios for CD4+/CD8+ cells, CD45RO+/CD45RA+
cells, CD4+CD45RO+/CD4+CD45RA+ cells and CD8+
CD45RO+/CD8+CD45RA+ cells were calculated after-
wards, with data derived from this analysis.
Statistical analysis
Data-entry and analysis was performed using Statistica 6.0
software. Means and standard deviations were calculated
for each parameter and were tested with one-way ANOVA.
DiVerences were considered statistically signiWcant at
p < 0.05.123
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In total, 27 patients with psoriasis and 10 normal subjects
without signs or symptoms of skin disease were included in
the present study. Table 1 summarizes the demographic
details and psoriasis related characteristics of the patients
with moderate-to-severe psoriasis, patients with mild psoria-
sis and normal subjects. Four out of 12 patients with mild
psoriasis had shown a minimal increase in the extent of
lesions; in the others the skin abnormalities were stable.
With respect to the 15 patients with moderate-to-severe-pso-
riasis, 12 had an increase of the extent of lesions during the
previous 4 weeks, whereas the other three had been stable.
Total cell counts
The total amount of gated cells (per microliter blood with-
drawn) in normal subjects was 2,220 § 301 cells l¡1
(mean § SEM). The cell-count in mild psoriasis was
1,923 § 230 cells l¡1. In contrast, patients with moderate-
to-severe psoriasis had cell counts of 498 § 95 cells l¡1.
No statistically signiWcant diVerence was observed between
normal subjects and patients with mild psoriasis. However,
a highly signiWcant diVerence (p < 0.0001) was observed
between mild and severe psoriasis. The CD4+/CD8+ ratios
in all three groups were in the same range, meaning no shift
occurred in the distribution of these subgroups of peripheral
blood lymphocytes.
The total number of lymphocytes, and the CD4+ and
CD8+ counts of the patients with moderate-to-severe
disease were also routinely measured at the GLP certiWed
Central Haematology Laboratory in our hospital, in which
the whole blood lysing method is the standard. Comparison
of both methods reveals an acceptable resemblance in
results, with lower counts of maximum 10%.
Lymphocyte subsets
Lymphocyte subsets as a percentage of total gated cells are
summarized in Fig. 1. CD4+, CD8+, CD45RA+ and
CD45RO+ cells are increased in patients with severe psori-
asis as compared to patients with mild psoriasis and normal
subjects (p < 0.0001 in all cases).
No signiWcant diVerences were observed between
patients with mild psoriasis and normal subjects.
Double labeling of lymphocytes revealed that the per-
centages of CD4+CD45RO+, CD4+CD45RA+ and
CD8+CD45RA+ cells were signiWcantly increased in mod-
erate-to-severe versus mild psoriasis (p < 0.001 in all
cases), whereas the percentage of CD8+CD45RO+ cells
was not increased signiWcantly (Fig. 2). Cell ratios
for CD4+/CD8+ cells, CD45RO+/CD45RA+ cells,
CD4CD45RO+/CD4CD45RA+ cells and CD8CD45RO+/
CD8CD45RA+ cells are summarized in Fig. 3.
Lymphocytes expressing NK cell receptors
CD94+ and CD161+ cells, expressed as a percentage of
total cells were increased in patients with moderate-to-
severe psoriasis, as compared to patients with mild psoriasis
Table 1 Demographic and pso-
riasis related characteristics of 
patient and subjects participating 
in the study (mean § SEM)
Moderate-to-severe 
psoriasis
Mild psoriasis Normal 
subjects
Demographics Age (years) 46.2 § 3.45 52.8 § 3.49 33.8 § 3.1
Male:female ratio 12:3 7:5 4:6
Psoriasis related 
characteristics
PASI-score 20.97 § 2.55 6.11 § 1.27 NA
Duration (years) 16.7 § 2.7 22.2 § 2.5 NA
Fig. 1 CD4, CD8, CD45RO 
and CD45RA subpopulations, 
expressed as a percentage of to-
tal lymphocyte counts. Compar-
ison between normal subjects, 
patients with mild- and patients 
with moderate-to-severe psoria-
sis. (*: p < 0.0001)123
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Figure 4 summarizes these observations. Again no statisti-
cally signiWcant diVerences were observed between normal
subjects and patients with a mild form of psoriasis.
With respect to double stained cells, we observed an
increase in the expression of both CD8+CD94+ cells as
well as CD8+CD161+ cells (markers for NK T subpopula-
tions) in patients with a more extensive form of psoriasis,
expressed as a percentage of the total amount of cells, as
compared to patients with mild psoriasis and normal subjects
(p < 0.008 and p < 0.009, respectively, results shown in
Fig. 5).
Correlation between PASI-score and lymphocyte subsets 
and cells expressing NK receptors
Linear regression analysis revealed no signiWcant correlation
between the individual PASI-scores and the quantiWcations
of lymphocyte subsets or cells with NK-cell receptors. Corre-
lation analysis between disease activity and peripheral




CD8CD45RA+ cells, as percent-
age of the total amount of lym-
phocytes, in three subgroups: 
moderate-to-severe psoriasis, 
mild psoriasis and normal sub-
jects (*: p < 0.001)




CD8CD45RA+ in normal sub-
jects, mild and moderate-to-se-
vere psoriasis (*: p < 0.05)
Fig. 4 CD94 and CD161 
subpopulations, expressed as a 
percentage of total lymphocyte 
counts. Comparison between 
normal subjects, patients with 
mild- and patients with moder-
ate-to-severe psoriasis (*: 
p < 0.05 and p < 0.001 
respectively)123
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with spreading lesions and those with stable plaque psoriasis.
Discussion
The results of this study show marked diVerences in absolute
cellcounts between the three patient groups. Our main goal
was to investigate whether there is a diVerence in the occur-
rence of biomarkers on circulating lymphocytes in mild psori-
asis versus more severe forms of the disease. One of the
criteria to qualify for a treatment with major systemic thera-
pies such as a biological is often a minimum PASI-score of 12
[4, 18]. We were interested whether this cut-oV point also
implies a diVerentiation between mild versus moderate/severe
psoriasis in terms of T-cell and NKT-cell subsets. The results
of the present study have shown us that there are indeed
marked diVerences between mild psoriasis and the more
severe forms of disease deWned by cut-oV point PASI 12.
A decrease of total lymphocyte counts, as percentage of
PBMC, and an increase in the percentage of
CD4+CD45RO+ cells in patients with moderate-to-severe
psoriasis has been reported before [10]. These patients (32
subjects) had an average PASI of 25.7 (10–48), and all had
had an exacerbation following infection. Patients had a
mixed morphology, from guttata psoriasis to chronic plaque
psoriasis. In the same study, however, a decrease in the
amount of CD4+ cells was described, which is in contrast
with the Wndings in our study. Other authors have reported
no signiWcant diVerence in total T-cells as percentage of
PBMC counts between patients with psoriasis and normal
subjects [3]. These patients (14 subjects) had an average
PASI of 23.5 § 10.6. However, no information was given
whether these patients had relapsing psoriasis. In the pres-
ent study, the patients with severe psoriasis had an exten-
sion of lesions during the wash out period (average increase
in PASI: 4.9). Therefore, the severity in our patients not
only comprises the extent of lesions but also activity of
lesions with progression and therefore, approaches the
characteristics of the patients reported by Lecewicz-Torún
et al. [10], who also reported a decrease of T-cells in
peripheral blood in psoriasis (expressed as percentage of
total PBMC). The decrease of lymphocyte counts,
expressed as a percentage, in peripheral blood in patients
with moderate-to-severe psoriasis is the reverse of the sub-
stantial accumulation of lymphocytes in psoriatic skin. The
most likely explanation for this paradox is an increased
inXux of cells into the skin of patients with severe disease.
Further studies, in which simultaneous measurements of
lesional and circulating T cells will be performed, need to
be carried out to support this hypothesis.
A striking observation is the increased percentage of
both CD4+ cells and CD8+ cells in patients with moderate-
to-severe psoriasis as compared to mild psoriasis and nor-
mal subjects, without a change in CD4/CD8 ratio. So far,
reports on the CD4+/CD8+ ratio in psoriasis have been at
variance [10, 11].
With respect to the double labeled lymphocytes, both the
percentage of CD4+CD45RO+ cells as well as the percent-
age of CD4+CD45RA+ cells is increased in patients with
moderate-to-severe psoriasis, in contrast to the absolute
decrease of total lymphocytes. The relative count of both
subsets is increased, whereas their ratio shows a tendency to
decrease (p = 0.0509). Thus, with increasing severity of dis-
ease, the increase in CD4+CD45RA+ cells seems to exceed
the increase in CD4+CD45RO+ cells. An explanation for
this phenomenon is the preferential migration of
CD4+CD45RO+ cells into lesional skin in extensive dis-
ease, resulting in a relative decrease of this subset of CD4+
lymphocytes in peripheral blood. This hypothesis supports
earlier studies where CD4+CD45RO+ cells have been
shown to be the major players in psoriatic plaques. Indeed,
CD4+ cells appear in a very early phase of the psoriatic pro-
cess. In a previous study, CD4+ cells have been detected in
the distant uninvolved skin of patients with active psoriasis
[22]. The percentage of CD8+CD45RO+ cells in patients
with moderate-to-severe psoriasis approached the percent-
ages in patients with mild psoriasis and normal subjects, in
Fig. 5 Cellcounts of 
CD8+CD94+ and 
CD8+CD161+ cells as 
percentage of total lymphocytes 
(*: p < 0.009)123
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signiWcant increase in peripheral blood. The impressive
under-representation of CD8+CD45RO+ lymphocytes as
compared to CD8+CD45RA+ lymphocytes in moderate to
severe psoriasis suggests a preferential inXux of
CD8+CD45RO+ cells into the skin. Both CD8+ cells, as
well as CD45RO+ cells are abundantly present in psoriatic
lesional skin. Previously, we have shown that in the outer
margin of the spreading psoriatic plaque the number of
CD8+ cells and CD45RO+ cells were increased [22]. There-
fore, the relative under-representation in peripheral blood of
CD45RO+ cells, in particular the CD8+ CD45RO+ cells,
most likely reXect the inXux of these cells into the skin in
patients with moderate-to-severe psoriasis in an active phase
of disease. However, further studies are needed to support
this hypothesis. Lymphocyte counts, preferably T-cells, in
skin as well as in the peripheral blood should be monitored
during a longer period of time, e.g., during exacerbation and
during disease-free intervals. The CD8+CD94+ cells and
CD8+CD161+ cells show a marked increase in patients with
moderate-to-severe psoriasis as compared to mild psoriasis
and normal subjects. The increases of these lymphocytes
expressing NK receptors in peripheral blood are accompa-
nied with increases of these cells in the psoriatic lesion.
The results of the present study suggest that in periphe-
ral blood of patients with moderate-to-severe psoriasis,
in contrast to the vast presence of T-cells in skin lesions,
the absolute lymphocyte counts are profoundly
decreased, without any change of CD4/CD8 ratio. The
relative under-representation of CD45RO+ cells, as
compared to CD45RA+ cells, in peripheral blood most
likely results from a massive inXux of memory eVector
T-cells into the psoriatic lesions in an active phase of
disease. Both in blood and skin of patients with moder-
ate-to-severe psoriasis the percentages of CD94+ and
CD161+ cells are increased. These results are compati-
ble with the functions of these cells. CD45RO+ cells
diVerentiate from CD45RA+ cells and represent
acquired immunity, whereas NK-T cells are able to act
without prior sensitization, representing innate immu-
nity [3]. In further research, more selective lymphocyte
markers are required in order to investigate the role of
peripheral blood T-cells in the pathogenesis of psoriasis,
and correlation studies between peripheral blood T-cells
and T-cells in skin are required in order to understand
the dynamics of compartmentalization of T-cell subsets
belonging to either the acquired or the innate immunity
system in psoriasis.
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